Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function?

Hepatobiliary and Pancreatic Diseases International

Volumn 11, Issue 3, 2012, Pages 307-313

  Okada, Masahiro ^a   Ishii, Kazunari ^a   Numata, Kazushi ^b   Hyodo, Tomoko ^a   Kumano, Seishi ^a   Kitano, Masayuki ^a   Kudo, Masatoshi ^a   Murakami, Takamichi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Bile duct; Gd EOB DTPA; Hepatobiliary phase; Liver; Magnetic resonance imaging

Indexed keywords

BILIRUBIN; CREATININE; GADOXETIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMAGE ANALYSIS; LIVER; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCORING SYSTEM; THREE DIMENSIONAL IMAGING;

EID: 84861972483     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(12)60165-9     Document Type: Article

References (14)

1. Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010;45:133-141.
2. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-792.
3. Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230:266-275.
4. Muhler A, Heinzelmann I, Weinmann HJ. Elimination of gadolinium-ethoxybenzyl-DTPA in a rat model of severely impaired liver and kidney excretory function. An experimental study in rats. Invest Radiol 1994;29:213-216.
5. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183:59-64.
6. Ryeom HK, Kim SH, Kim JY, Kim HJ, Lee JM, Chang YM, et al. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol 2004;5:231-239.
7. Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 2008;18:1577-1586.
8. Takao H, Akai H, Tajima T, Kiryu S, Watanabe Y, Imamura H, et al. MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol 2011; 77:325-329.
9. Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, et al. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 2009;30:1042-1046.
10. Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M, et al. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 2010;255:824-833.
11. Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009;44:793-798.
12. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. World Medical Association. Bull World Health Organ 2001; 79:373-374.
13. Carlos RC, Branam JD, Dong Q, Hussain HK, Francis IR. Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol 2002;9:1322-1325.
14. Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, et al. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. AJR Am J Roentgenol 2009;193:1053-1060.